ArticleBiomedicines2026

CA 15.3, Metastatic Burden, and Overall Survival in Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer: Real-World Evidence from Peru.

Guillermo Valencia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.